N19 likely acts as an HSP90 inhibitor and kills EGFR-mutated NSCLC cells via simultaneous degradation of EGFR and cMET both proteins by ubiquitin proteasomes. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.